June 13, 2023 — A recent study highlights that implantable cardioverter-defibrillator (ICD) patients with new-onset atrial high-rate episodes (AHRE) often show high stroke risk while not being on oral anticoagulation (OAC), underlining the relevance of continuous AHRE burden monitoring.1 The study also reports that the combination of BIOTRONIK’s unique 

Rapid adoption of wireless cardiac monitoring devices and continuous advancements in remote monitoring technology are generating significant business opportunities for companies in the cardiovascular diagnostic and monitoring devices market

The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to record a 

June 12, 2023 — New research published in JMIR Cardio reveals the remarkable potential of artificial intelligence (AI) technology in analyzing coronary angiography, a common diagnostic procedure for coronary artery disease. Led by Dr In Tae Moon, the study conducted at Uijeongbu Eulji University Hospital

June 12, 2023 — An effective treatment for most stroke victims — even those who, today, are unable to gain access to care within the first few hours. This is the goal of an experimental method that has been tested with great success in an international study headed by the University of Gothenburg. 

June 12, 2023 — Medtech startup Avatar Medical announced today that its virtual reality (VR) surgical planning solution has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). 

Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery.

June 9, 2023 — Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language. This approach can enhance the accuracy and effectiveness of ECG-related diagnoses, especially for cardiac conditions where limited data is available on which to train. 

June 9, 2023 — Dasi Simulations announced it received FDA clearance for its artificial intelligence model for preprocedure transcatheter aortic valve replacement modeling. 

The AI (Precision TAVI) is the company’s first product to be cleared by the FDA, according to a company press release. 

June 9, 2023 — Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID-19 infection, were more likely to experience heart issues associated with long COVID, according to a recent Houston Method

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now